GAMZU ELKAN R 4
4 · PHARMOS CORP · Filed Aug 18, 2004
Insider Transaction Report
Form 4
PHARMOS CORPPARS
GAMZU ELKAN R
Director
Transactions
- Sale
Common Stock
2004-08-17$3.45/sh−100$345→ 0 total - Exercise/Conversion
Stock Options
2004-08-17−1,250→ 11,500 totalExercise: $1.02From: 2004-08-17Exp: 2013-02-17→ Common Stock (1,250 underlying) - Sale
Common Stock
2004-08-17$3.43/sh−1,150$3,945→ 100 total - Exercise/Conversion
Common Stock
2004-08-17$1.02/sh+1,250$1,275→ 1,250 total
Footnotes (2)
- [F1]Sale is pursuant to a 10b5-1 trading plan previously established by Dr. Gamzu.
- [F2]The 1,250 options exercied became exercisable on 8/17/04. The remaining 11,500 options become exercisable in ten equal quarterly increments between 11/17/04 and 2/17/07.